NCT07051005 Feasibility of a Tailored Online Self-compassion Intervention
| NCT ID | NCT07051005 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Canterbury Christ Church University |
| Condition | Type 1 Diabetes Mellitus |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-06-18 |
| Primary Completion | 2026-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-06-18 with a primary completion date of 2026-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to examine the feasibility and acceptability of an online programme that is based on Compassionate Mind Training (CMT) over four-weeks. The programme intends to share information and strategies to reduce diabetes distress, self-criticism, and shame, and improve physical health in people who have Type 1 and Type 2 Diabetes Mellitus.
Eligibility Criteria
Inclusion Criteria: * 18 years old or older. * Diagnosed with Type 1 or Type 2 diabetes by a clinician in the NHS more than one year ago. * Self-managing theircondition. * Identified by their NHS team as needing support with their mental health due to diabetes-related distress. Exclusion Criteria: * \<18 * Individuals experiencing a current mental health crisis, including severe depression, active suicidal thoughts, or acute psychosis * Unable to read/speak English * Gestational diabetes, Wolfram, and other rarer conditions * Individuals currently experiencing severe substance abuse issues that could interfere with participation in the programme * Individuals without reliable access to the internet and a compatible device (computer or smartphone).
Contact & Investigator
Fergal Jones, PhD
STUDY CHAIR
Canterbury Christ Church University
Frequently Asked Questions
Who can join the NCT07051005 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Type 1 Diabetes Mellitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07051005 currently recruiting?
Yes, NCT07051005 is actively recruiting participants. Contact the research team at js1624@canterbury.ac.uk for enrollment information.
Where is the NCT07051005 trial being conducted?
This trial is being conducted at Bangor, United Kingdom, London, United Kingdom.
Who is sponsoring the NCT07051005 clinical trial?
NCT07051005 is sponsored by Canterbury Christ Church University. The principal investigator is Fergal Jones, PhD at Canterbury Christ Church University. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.